Evidence map›Paper›PMID 37855865›Full record

ArticleBulletin of experimental biology and medicine2023

Ischemia-Modified Albumin and Antioxidant Protection in Newborns with Asphyxia of Varying Severity.

S F Delsuz, R I Shalina, E Ya Karaganova, M A Kurtser, I V Babenkova, Yu O Teselkin, A N Osipov, Yu A Vladimirov

Abstract read
PubMed Publisher
In one paragraph

Article in Bulletin of experimental biology and medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.6field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

S F DelsuzPirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.
R I ShalinaPirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.
E Ya KaraganovaPirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.
M A KurtserPirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.
I V BabenkovaPirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.
Yu O TeselkinPirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia. teselkin-box@mail.ru.
A N OsipovPirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.
Yu A VladimirovPirogov Russian National Research Medical University, Ministry of Health of the Russian Federation, Moscow, Russia.
Ministry of Health of the Russian Federation · RUPirogov Russian National Research Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The content of ischemia-modified albumin (IMA), serum albumin, and antioxidant capacity of blood serum was studied in healthy newborns and in newborns with moderate and severe asphyxia on days 1-2 and 3-4 of the postnatal period. Changes in these indicators were found in both groups of newborns with birth asphyxia in comparison with the group of healthy newborns and were more pronounced in children with severe asphyxia. An increase in the IMA level (by 1.6 times; p<0.001) and antioxidant capacity of blood serum (by 2.4 times; p<0.001) and a decrease in serum albumin content (by 1.5 times; p<0.001) were found in severe asphyxia on days 1-2. Analysis of changes in these indicators by days 3-4 allows to talk about a decrease in the intensity of free-radical reactions in newborns with birth asphyxia during complex therapy.

Indexed as

AntioxidantsSerum AlbuminAsphyxiaBiomarkersCase-Control StudiesChildHumansInfant, NewbornOxidative StressSerum Albumin, HumanAntioxidantsBiomarkersischemia-modified albuminSerum AlbuminSerum Albumin, Humanantioxidant capacity of blood serumischemia-modified albuminnewborns with asphyxiaoxidative stressserum albumin

Identifiers

PMID37855865
OpenAlexW4387765007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.